SNORA80E and non-small cell lung carcinoma: To examine whether snoRA42 knockdown was associated with repression of in vivo tumorigenicity, we subcutaneously inoculated CD133+ Calu-1 NSCLC cells treated with either snoRA42-siRNA or scrambled siRNA into the flanks of mice (5 × 105 cells/mouse).